Weil, Gotshal & Manges is advising Avista Healthcare Partners and its portfolio company WellSpring Consumer Healthcare in the transaction. WellSpring executed the acquisition of vH essentials...
You must be a Standard 1 Year member to access this content.
Gómez-Pinzón represented Banca de Inversión Bancolombia and Avista in the transaction. Banca de Inversión Bancolombia and Avista announced the structuring, negotiation and closing of their co-investment...
You must be a Standard 1 Year member to access this content.
Willkie Farr & Gallagher represented Avista Capital Partners and its portfolio company Solmetex in the transaction. Solmetex, LLC, a leading provider of dental waterline products and...
You must be a Standard 1 Year member to access this content.
Weil advised WellSpring Consumer Healthcare and Avista Capital Partners on the deal. WellSpring Consumer Healthcare announced the acquisition of a portfolio of well-recognized and trusted over-the-counter...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Avista Capital Partners in the transaction. Avista Capital Partners executed its acquisition of Taconic Biosciences, a provider of genetically engineered research models...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Avista Capital Partners and its portfolio company United BioSource LLC on the deal. Avista Capital Partners and its portfolio company United BioSource...
You must be a Standard 1 Year member to access this content.
Ropes & Gray acted as legal advisor to Avista Capital Partners, while Morgan Lewis represented Probo Medical in the transaction. Avista Capital Partners executed its acquisition...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Avista Capital Partners, Nordic Capital and Acino on the deal. Acino announced its sale to ADQ, one of the Middle East’s largest holding...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Avista Capital Partners, while Paul Hastings LLP represented eMolecules in the transaction. Avista Capital Partners signed its agreement to invest in eMolecules, a...
You must be a Standard 1 Year member to access this content.
